The Outlook article ‘Combinations on trial’ (Nature 552, S67–S69; 2017) overstated the number of immunotherapeutic agents in development at more than 2,400. In fact, there are roughly 2,000.
Nature 553, 155 (2018)
Sign up for the daily Nature Briefing email newsletter
Stay up to date with what matters in science and why, handpicked from Nature and other publications worldwide.